Bioventus Inc.是一家全球化医疗技术企业,专注于骨科生物制剂领域,研发并商业化促进骨关节愈合、肌肉骨骼疼痛管理及再生护理的相关产品,服务全球多地的骨科临床医师、康复师及患者群体。
GKOS
GLAUKOS Corp
营收
$150.6M
净利润
$9.4M
UFPT
UFP TECHNOLOGIES INC
$148.9M
$17.6M
NVCR
NovoCure Ltd
$174.1M
$-71.1M
DHT
DHT Holdings, Inc.
$107.3M
$44.8M
ATRC
AtriCure, Inc.
$140.5M
N/A
MDXG
MIMEDX GROUP, INC.
$118.1M
$15.2M
RNST
RENASANT CORP
$273.8M
$88.2M
AORT
ARTIVION, INC.
$116.0M
$2.4M